In re: 626 Hospice, Inc.

United States Bankruptcy Court, C.D. California·Decided July 23, 2026·No. 2:24-ap-01108·Unknown

Opinion

FILED & ENTERED JUL 23 2026 C C L en E t R ra K l U D . i S st . r B ic A t N of K C R a U li P fo T r C n Y ia COURT BY g o n z a l e z DEPUTY CLERK In re: Case No.: 2:22-bk-12904-WB

626 HOSPICE, INC., Chapter: 7 Debtor(s). A d v e r s a r y N o . : 2 :24-ap-01108 -WB HOWARD EHRENBERG, Chapter 7 Trustee, M E M O R A N DUM OF DECISION Plaintiff(s), vs. Date: September 30, 2025 CLEO TSOLAKOGLOU WILLIAMS, Time: 2:00 PM an individual, Location: 255 E. Temple Street Courtroom 1375 Defendant(s). Los Angeles, CA 90012

This adversary proceeding arises in the bankruptcy case of 626 Hospice, Inc. (“Debtor”), a Medicare and Medi-Cal hospice provider whose principal, Gladwin Gill (“Mr. Gill”), systematically diverted Debtor’s reimbursement income over several years. Plaintiff, Howard Ehrenberg, Chapter 7 Trustee (“Trustee”), moves for summary judgment1 against Defendant Cleo Tsolakoglou Williams (“Defendant” or “Williams”) to avoid and recover $299,500 in transfers (the “Four-Year Transfers”) as fraudulent transfers under 11 U.S.C. §§ 544(b), 548 and California Civil Code §§ 3439.04(a), 3439.05, 3439.07.2 The Four-Year Transfers were payments made to Defendant in connection with the sale of her medical practice, Asclepion Family Medical Group (“Asclepion”), to Boston Medical Center, Inc. (“BMC”), an entity controlled by Mr. Gill. The payments were not funded by the purchaser identified on the Purchase Agreement, BMC, but were funded from money that Mr. Gill and his daughter, Natasha Gill (“Natasha”), had misappropriated from Debtor’s reimbursement income. Debtor received no interest in Asclepion and no value of any kind in return. Defendant opposes the motion primarily on the grounds that she acted in good faith and provided reasonably equivalent value for the payments she received. In support of her opposition, she submitted several declarations. For the reasons set forth below, the declarations are legally insufficient to raise a genuine dispute of material fact. The undisputed record establishes that Defendant received payments from entities that had no contractual obligation to pay her, which would have placed a reasonable person in her position on inquiry notice that something

1 The Trustee’s motion states that this Court has jurisdiction to make recommendations to the District Court. That procedure is not necessary here, as both parties have consented to this Court’s entry of a final judgment and/or order in this adversary proceeding. See Joint Status Report (docket no. 5). 2 Unless specified otherwise, all chapter and section references are to the Bankruptcy Code, 11 U.S.C. §§ 101-1532, “Rule” references are to the Federal Rules of Bankruptcy Procedure, “Civil Rule” references are to the Federal Rules of Civil Procedure, “LBR” references are to the Local Bankruptcy Rules of the United States Bankruptcy Court for the Central District of California (“LBR”), and “CC” references are to the California Civil Code. was amiss. Her failure to investigate why that was the case precludes a determination of good faith. The value she provided, her Asclepion shares and goodwill, went to BMC, an entity controlled by Mr. Gill, and not to Debtor, whose funds were used to make the payments. For the reasons set forth below, the Court determines that the Trustee has established both actual and constructive fraudulent transfers and that Defendant has failed to raise a genuine dispute of material fact as to good faith and reasonably equivalent value. The motion for summary judgment is therefore granted. A. Debtor and its Medicare/Medi-Cal Operations Debtor was formed on May 16, 2011 and entered into a Provider Agreement with the U.S. Department of Health and Human Services (“HHS”) on October 28, 2014. That agreement authorized Debtor to provide hospice care services, including routine home care, continuous home care, and inpatient respite care, and to submit invoices to HHS for reimbursement. Reimbursements were administered by the National Government Services (“NGS”), an administrative contractor for HHS. Medicare reimbursements were subject to an annual year-end review to determine whether payments exceeded a cap established by the Code of Federal Regulations, and any overpayment was required to be returned upon notice from the NGS. In May 2018, Mr. Gill, through a company he controlled and managed called American Academy of Palliative Care Services, Inc., acquired Debtor. At all times thereafter, Mr. Gill exercised control over Debtor directly or through his family members, his daughter, Natasha, who served as Debtor’s Chief Financial Officer, and his wife, Amelou Gill. Debtor’s primary bank account was a Citibank account (ending 4716). Medicare reimbursements were wired to that account. B. Gill Family Scheme On April 5, 2019, NGS sent Debtor its first overpayment notice, stating that Debtor received a Medicare overpayment of $149,100.09 for the year ending September 30, 2018 and was required to return those funds. Debtor did not appeal that determination. Rather than comply, Mr. Gill and Natasha commenced a scheme to divert the overpayments. Within twenty days after this first overpayment notice, on April 25, 2019, Mr. Gill opened a Bank of America checking account (ending 1578) in the name of California Hospice (“California Hospice”), a California corporation he formed in June 2018. California Hospice had no operations, no employees, and no expenses, and it did not even have a bank account prior to April 2019. Another Bank of America account (ending 3756) was opened in the name of California Hospice on May 7, 2019. Over the next three years, Mr. Gill and Natasha diverted 113 Medi-Cal reimbursement checks that were made payable to “626 Hospice, Inc.,” totaling approximately $1.2 million, into the California Hospice accounts rather than Debtor’s account (ending 4716). Medicare reimbursements that were wired directly into Debtor’s account (ending 4716) were transferred out through checks payable to California Hospice and other entities controlled by the Gill family. Mr. Gill and Natasha used the diverted funds for their own personal use and to acquire other businesses. Additional overpayment notices followed: June 5, 2020 ($565,818.82); December 3, 2020 ($31,562.18); March 30, 2021 ($575,233.00), August 6, 2021 ($43,312.66), October 29, 2021 ($55,566.68), April 5, 2022 ($522,177.07), and a final one on June 7, 2022 ($858,644.93). Debtor repaid only a fraction of what was owed to HHS. C. Asclepion Sale Defendant was the sole owner of Asclepion, a medical practice that she operated for over 20 years. In 2020, Mr. Gill negotiated to purchase Defendant’s interest in Asclepion. On March 9, 2020, the Defendant signed a Purchase Agreement, and on April 23, 2020, Mr. Gill signed the Purchase Agreement, pursuant to which BMC agreed to purchase Defendant’s 100% interest in Asclepion and all its assets for $250,000. BMC was the sole purchaser and party obligated under the Purchase Agreement. Debtor was neither a party to, nor mentioned in, the Purchase Agreement. On April 30, 2020, Defendant and Mr. Gill, on behalf of BMC, entered into an Addendum to Purchase Agreement (“Addendum”), and on May 4, 2020, they entered into a Share Interest Transfer Agreement, stating that the parties intended that Defendant’s 100% interest in Asclepion was to be transferred to “Boston Medical Center, a California corporation.” Mr. Gill never transferred any interest in Asclepion to Debtor. The Trustee does not know who currently possesses an interest in Asclepion. Despite BMC clearly being obligated

Free access — add to your briefcase to read the full text and ask questions with AI

In re: 626 Hospice, Inc., (Cal. 2026).

In re: 626 Hospice, Inc. (In re: 626 Hospice, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related